Hematology, Transfusion and Cell Therapy

Advanced Search

Share

English Português

January - February 2015

Hematology, Transfusion and Cell Therapy

Hematology, Transfusion and Cell Therapy

ISSN: 2531-1379

Hematology, Transfusion and Cell Therapy is a quarterly scientific publication of the Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), Associazione Italo-Brasiliana di Ematologia (AIBE), Eurasian Hematology Oncology Group (EHOG), and Sociedade Brasileira de Oncologia Pediátrica (SOBOPE).

Hematology, Transfusion and Cell Therapy publishes original articles, review articles and case reports covering various areas in the field of hematology and hemotherapy. The journal was previously published, until 2016, as Revista Brasileira de Hematologia e Hemoterapia.

ISSN print: 2531-1379
ISSN online: 2531-1387

Published by Elsevier Editora Ltda, Rio de Janeiro, Brazil.

See more

Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular. HEMO 2024. List of conference abstracts.

Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular. HEMO 2024. List of conference abstracts.

Indexed in:

Scopus, Medline, Directory of Open Access Journals (DOAJ), PubMed Central (PMC), Emerging Sources Citation Index (ESCI), SCImago Journal Rank (SJR), SNIP

See more

Follow us:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

See more

Impact factor 2023

1.8

Citescore

CiteScore measures average citations received per document published.

See more

Citescore 2023

2.4

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more

SJR 2023

0.376

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more

SNIP 2023

0.565

View more metrics

Open Access Option

Journal Information

Previous Issue | Next Issue

Issue

portada-S1516848415X00028

Vol. 37. Issue 1.

Pages 1-70 (January - February 2015)

Editorial

Many thanks to our eternal Editor of the Revista Brasileira de Hematologia e Hemoterapia, Professor Milton Artur Ruiz

Cármino Antonio de Souza

Rev Bras Hematol Hemoter. 2015;37:1-2

Open access

Share

Scientific comment

Myeloid leukemia: are we getting better?

Nelson Hamerschlak

Rev Bras Hematol Hemoter. 2015;37:3-4

Open access

Share

The invisibility of sickle cell disease in Brazil: lessons from a study in Maranhão

Marcos Borato Viana

Rev Bras Hematol Hemoter. 2015;37:5-6

Open access

Share

Original

Trends in mortality of adult patients diagnosed with myeloid leukemia from 1994 to 2011 in southeastern Brazil

Fernando Callera, Alexandra Fernandes Callera, Evandro Secchi Rosa

Rev Bras Hematol Hemoter. 2015;37:7-11

Open access

Share

Trends in mortality and hospital admissions of sickle cell disease patients before and after the newborn screening program in Maranhão, Brazil

Ana Ranoy Gomes Lima, Valdinar Sousa Ribeiro, Dario Itapary Nicolau

Rev Bras Hematol Hemoter. 2015;37:12-6

Open access

Share

Diversity of breakpoints of variant Philadelphia chromosomes in chronic myeloid leukemia in Brazilian patients

Maria de Lourdes Lopes Ferrari Chauffaille, Ana Carolina de Almeida Bandeira, Aline Schiavoni Guarnieri da Silva

Rev Bras Hematol Hemoter. 2015;37:17-20

Open access

Share

Acute myeloid leukemia: survival analysis of patients at a university hospital of Paraná

Sergio Lunardon Padilha, Emannuely Juliani dos Santos Souza, Marcela Coriolano Cruz Matos, Natália Ramos Domino

Rev Bras Hematol Hemoter. 2015;37:21-7

Open access

Share

Results of high-risk neutropenia therapy of hematology–oncology patients in a university hospital in Uruguay

Matilde Boada Burutaran, Regina Guadagna, Sofia Grille, Mariana Stevenazzi, Cecilia Guillermo, Lilian Diaz

Rev Bras Hematol Hemoter. 2015;37:28-33

Open access

Share

Immunohistochemical evaluation of CD20 expression in patients with multiple myeloma

Irfan Yavasoglu, Gokhan Sargin, Gurhan Kadikoylu, Firuzan Kacar Doger, Zahit Bolaman

Rev Bras Hematol Hemoter. 2015;37:34-7

Open access

Share

Association between maternal and fetal factors and quality of cord blood as a source of stem cells

Rodrigo Dias Nunes, Flávia Maria Zandavalli

Rev Bras Hematol Hemoter. 2015;37:38-42

Open access

Share

Prevalence of anemia in a sample of elderly southeastern Brazilians

Fernando Callera, Alexandra Fernandes Callera, Adriano Moraes da Silva, Evandro Secchi Rosa

Rev Bras Hematol Hemoter. 2015;37:43-7

Open access

Share

Identifying the similarities and differences between single nucleotide polymorphism array (SNPa) analysis and karyotyping in acute myeloid leukemia and myelodysplastic syndromes

Thiago Rodrigo de Noronha, Sandra Serson Rohr, Maria de Lourdes Lopes Ferrari Chauffaille

Rev Bras Hematol Hemoter. 2015;37:48-54

Open access

Share

Case report

A case of chronic myeloid leukemia with the m-bcr (p190) molecular rearrangement identified during treatment

Mariana Beatriz Asinari, Maximiliano Zeballos, Sturich Alicia, Brenda Nidia Ricchi, Ana Lisa Basquiera

Rev Bras Hematol Hemoter. 2015;37:55-7

Open access

Share

Special article

Teaching transfusion medicine: current situation and proposals for proper medical training

Gustavo de Freitas Flausino, Flávio Ferreira Nunes, Júnia Guimarães Mourão Cioffi, Anna Bárbara de Freitas Carneiro Proietti

Rev Bras Hematol Hemoter. 2015;37:58-62

Open access

Share

Motivating medical students to learn basic science concepts using chronic myeloid leukemia as an integration theme

Sara Teresinha Olalla Saad, Hernandes Faustino Carvalho

Rev Bras Hematol Hemoter. 2015;37:63-6

Open access

Share

Letter

Why and how validate criteria by manual smear review to improve laboratory productivity?

Helena Zerlotti Wolf Grotto

Rev Bras Hematol Hemoter. 2015;37:67-8

Open access

Share

To follow or not to follow the recommendations regarding microscopic analysis of the Clinical and Laboratory Standards Institute H20-A2 to validate the criteria for blood smear review?

Samuel Ricardo Comar, Mariester Malvezzi, Ricardo Pasquini

Rev Bras Hematol Hemoter. 2015;37:69-70

Open access

Share

Publish in

Hematology, Transfusion and Cell Therapy

Hematology, Transfusion and Cell Therapy is a member and subscribes the principles of, the Committee on Publication Ethics (COPE)
www.publicationethics.org.

Idiomas

Hematology, Transfusion and Cell Therapy

Home
All contents
Publish your article
About the journal
- Aims and scope
- Editorial Board
Metrics